Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China flag China · Delayed Price · Currency is CNY
3.680
-0.010 (-0.27%)
Apr 29, 2026, 3:00 PM CST

SHA:600664 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,1823,4373,6343,0602,4331,592
Cash & Short-Term Investments
3,1823,4373,6343,0602,4331,592
Cash Growth
13.55%-5.44%18.75%25.76%52.85%77.49%
Accounts Receivable
5,2354,7484,9854,9614,8184,749
Other Receivables
140.08129.57130.8146.47178.5185.86
Receivables
5,3754,8785,1165,1074,9974,835
Inventory
2,1612,0611,8911,9241,8042,064
Prepaid Expenses
--9.6710.74.93-
Other Current Assets
319.27277.75327.8293.61320.05242.45
Total Current Assets
11,03810,65310,97910,3969,5608,733
Property, Plant & Equipment
2,3132,3382,3852,4682,6412,835
Long-Term Investments
31.0631.0633.4938.4237.6239.32
Goodwill
39.1639.1639.1639.1539.1539.15
Other Intangible Assets
407.58411.55408.4451.14444.21480.78
Long-Term Deferred Tax Assets
614.33607.84603.74597.85600.19599.44
Long-Term Deferred Charges
90.7988.5363.441.2963.9671.76
Other Long-Term Assets
118.59118.59104.2480.1648.8444.11
Total Assets
14,65314,28814,61614,11213,43512,842
Accounts Payable
4,2314,0324,0393,9513,5103,482
Accrued Expenses
483.69566.55618.37597.07668.02628.3
Short-Term Debt
1,0211,0411,5541,6581,9332,078
Current Portion of Long-Term Debt
139.29140.67104.76104.04103.64102.92
Current Portion of Leases
--36.2331.2135.9336.74
Current Income Taxes Payable
137.4181.8257.2180.198.2985.17
Current Unearned Revenue
106.22122.01311.61282.45235.87119.73
Other Current Liabilities
1,4921,4381,3831,5391,4171,322
Total Current Liabilities
7,6117,4238,1058,2438,0027,855
Long-Term Debt
31.4831.4831.732.6333.1934.09
Long-Term Leases
27.9130.1635.3231.0843.6861.61
Long-Term Unearned Revenue
296.53290.97300.74319.07333.61375.1
Long-Term Deferred Tax Liabilities
7.247.595.736.916.291.68
Other Long-Term Liabilities
42.7842.7847.9856.6469.794.7
Total Liabilities
8,0167,8268,5268,6898,4888,422
Common Stock
2,5192,5192,5192,5212,5262,518
Additional Paid-In Capital
674.09663.33684.11685.32688.6675.43
Retained Earnings
4,4334,2723,9113,2822,8872,426
Treasury Stock
----3.98-13.01-15.53
Comprehensive Income & Other
-1,766-1,766-1,763-1,760-1,760-1,757
Total Common Equity
5,8605,6885,3504,7244,3283,847
Minority Interest
776.08774739.49698.75618.87573.25
Shareholders' Equity
6,6366,4626,0895,4234,9474,420
Total Liabilities & Equity
14,65314,28814,61614,11213,43512,842
Total Debt
1,2201,2431,7621,8572,1492,313
Net Cash (Debt)
1,9622,1931,8721,203284.1-720.94
Net Cash Growth
35.57%17.18%55.56%323.57%--
Net Cash Per Share
0.760.850.740.490.11-0.29
Filing Date Shares Outstanding
2,6862,7482,5192,5212,5262,518
Total Common Shares Outstanding
2,6862,7482,5192,5212,5262,518
Working Capital
3,4273,2302,8742,1531,558878.23
Book Value Per Share
2.182.072.121.871.711.53
Tangible Book Value
5,4135,2374,9024,2343,8443,327
Tangible Book Value Per Share
2.021.911.951.681.521.32
Buildings
--4,6594,6444,7024,683
Machinery
--3,3083,2143,1693,545
Construction In Progress
--74.7369.1266.22164.92
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.